| Year |
Citation |
Score |
| 2024 |
Guo Q, Ping L, Dammer EB, Yin L, Xu K, Shantaraman A, Fox EJ, Golde TE, Johnson ECB, Roberts BR, Lah JJ, Levey AI, Seyfried NT. Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease. Research Square. PMID 38464223 DOI: 10.21203/rs.3.rs-3933136/v1 |
0.387 |
|
| 2024 |
Schwinne M, Alonso A, Roberts BR, Hickle S, Verberk IMW, Epenge E, Gikelekele G, Tsengele N, Kavugho I, Mampunza S, Yarasheski KE, Teunissen CE, Stringer A, Levey A, Ikanga J. The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa. Journal of Alzheimer's Disease : Jad. 97: 1353-1363. PMID 38306056 DOI: 10.3233/JAD-230976 |
0.349 |
|
| 2024 |
Odenkirk MT, Zheng X, Kyle JE, Stratton KG, Nicora CD, Bloodsworth KJ, Mclean CA, Masters CL, Monroe ME, Doecke JD, Smith RD, Burnum-Johnson KE, Roberts BR, Baker ES. Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions. Journal of Proteome Research. PMID 38236019 DOI: 10.1021/acs.jproteome.3c00604 |
0.469 |
|
| 2023 |
Schwinne M, Alonso A, Roberts BR, Hickle S, Verberk IM, Epenge E, Gikelekele G, Tsengele N, Kavugho I, Mampunza S, Yarasheski KE, Teunissen CE, Stringer A, Levey A, Ikanga J. The Association of Alzheimer's Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa. Medrxiv : the Preprint Server For Health Sciences. PMID 37693503 DOI: 10.1101/2023.08.28.23294740 |
0.349 |
|
| 2023 |
Haque R, Watson CM, Liu J, Carter EK, Duong DM, Lah JJ, Wingo AP, Roberts BR, Johnson ECB, Saykin AJ, Shaw LM, Seyfried NT, Wingo TS, Levey AI. A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease. Science Translational Medicine. 15: eadg4122. PMID 37672565 DOI: 10.1126/scitranslmed.adg4122 |
0.345 |
|
| 2023 |
Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, Barthélemy NR, Karch CM, Xiong C, Cruchaga C, Perrin RJ, ... ... Roberts BR, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine. PMID 37550416 DOI: 10.1038/s41591-023-02476-4 |
0.43 |
|
| 2023 |
Modeste ES, Ping L, Watson CM, Duong DM, Dammer EB, Johnson ECB, Roberts BR, Lah JJ, Levey AI, Seyfried NT. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease. Molecular Neurodegeneration. 18: 48. PMID 37468915 DOI: 10.1186/s13024-023-00638-z |
0.342 |
|
| 2023 |
Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, Johnson ECB, Levey AI, Lah JJ, Roberts BR, Seyfried NT. Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer's Disease. Scientific Data. 10: 261. PMID 37160957 DOI: 10.1038/s41597-023-02158-3 |
0.385 |
|
| 2023 |
Lah J, Tandon R, Zhao L, Watson C, Elmor M, Heilman C, Sanders K, Hales C, Yang H, Loring D, Goldstein F, Hanfelt J, Duong D, Johnson ECB, Wingo A, ... ... Roberts B, et al. Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer's Disease. Research Square. PMID 36909654 DOI: 10.21203/rs.3.rs-2577025/v1 |
0.389 |
|
| 2023 |
Roberts BR, Laffoon SB, Roberts AM, Porter T, Fowler C, Masters CL, Dratz EA, Laws SM. Discovery of a Missense Mutation (Q222K) of the Gene from the Australian Imaging, Biomarker and Lifestyle Study. Journal of Alzheimer's Disease Reports. 7: 165-172. PMID 36891255 DOI: 10.3233/ADR-220075 |
0.373 |
|
| 2022 |
Ayton S, Janelidze S, Kalinowski P, Palmqvist S, Belaidi AA, Stomrud E, Roberts A, Roberts B, Hansson O, Bush AI. CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36357168 DOI: 10.1136/jnnp-2022-330052 |
0.357 |
|
| 2022 |
Mukherjee S, Dubois C, Perez K, Varghese S, Birchall IE, Leckey M, Davydova N, McLean C, Nisbet RM, Roberts BR, Li QX, Masters CL, Streltsov VA. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains. Journal of Neurochemistry. PMID 36271678 DOI: 10.1111/jnc.15713 |
0.658 |
|
| 2022 |
Mukherjee S, Fjeldsted JC, Masters CL, Roberts BR. Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software. Analytical and Bioanalytical Chemistry. PMID 35426495 DOI: 10.1007/s00216-022-04055-x |
0.649 |
|
| 2022 |
Laffoon SB, Doecke JD, Roberts AM, Vance JA, Reeves BD, Pertile KK, Rumble RL, Fowler CJ, Trounson B, Ames D, Martins R, Bush AI, Masters CL, Grieco PA, Dratz EA, ... Roberts BR, et al. Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease. Proteome Science. 20: 2. PMID 35081972 DOI: 10.1186/s12953-021-00185-9 |
0.42 |
|
| 2021 |
Klatt S, Doecke JD, Roberts A, Boughton BA, Masters CL, Horne M, Roberts BR. A six-metabolite panel as potential blood-based biomarkers for Parkinson's disease. Npj Parkinson's Disease. 7: 94. PMID 34650080 DOI: 10.1038/s41531-021-00239-x |
0.393 |
|
| 2021 |
Mukherjee S, Perez KA, Dubois C, Nisbet RM, Li QX, Varghese S, Jin L, Birchall I, Streltsov VA, Vella LJ, McLean C, Barham KJ, Roberts BR, Masters CL. Citrullination of Amyloid-β Peptides in Alzheimer's Disease. Acs Chemical Neuroscience. PMID 34519476 DOI: 10.1021/acschemneuro.1c00474 |
0.678 |
|
| 2021 |
Mukherjee S, Perez KA, Lago LC, Klatt S, McLean CA, Birchall IE, Barnham KJ, Masters CL, Roberts BR. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease. Brain Communications. 3: fcab028. PMID 33928245 DOI: 10.1093/braincomms/fcab028 |
0.653 |
|
| 2020 |
Ayton S, Janelidze S, Roberts B, Palmqvist S, Kalinowski P, Diouf I, Belaidi AA, Stomrud E, Bush AI, Hansson O. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age. Progress in Neurobiology. 101904. PMID 32882319 DOI: 10.1016/J.Pneurobio.2020.101904 |
0.355 |
|
| 2020 |
Gunn AP, Wong BX, McLean C, Fowler C, Barnard PJ, Duce JA, Roberts BR. Increased glutaminyl cyclase activity in brain of Alzheimer's disease individuals. Journal of Neurochemistry. PMID 32614980 DOI: 10.1111/Jnc.15114 |
0.396 |
|
| 2020 |
Klatt S, Roberts A, Lothian A, Masters CL, Cappai R, Fowler C, Roberts BR. Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometry. Analytical and Bioanalytical Chemistry. PMID 32030493 DOI: 10.1007/s00216-020-02439-5 |
0.353 |
|
| 2019 |
Malakooti N, Roberts B, Pritchard MA, Volitakis I, Kim RC, Lott IT, McLean CA, Finkelstein DI, Adlard PA. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology. Metallomics : Integrated Biometal Science. PMID 31764918 DOI: 10.1039/C9Mt00196D |
0.353 |
|
| 2019 |
Mukherjee S, Fang M, Kok WM, Kapp EA, Thombare VJ, Huguet R, Hutton CA, Reid GE, Roberts BR. Establishing Signature Fragments for Identification and Sequencing of Dityrosine Cross-linked Peptides using Ultraviolet Photodissociation Mass Spectrometry. Analytical Chemistry. PMID 31490671 DOI: 10.1021/Acs.Analchem.9B02986 |
0.516 |
|
| 2019 |
Masters CL, Nakamura A, Yanagisawa K, Huang X, Gu BJ, Villemagne VL, Barnham KJ, Perez K, Vella L, Li Q, Roberts BR, Fowler C. F2-07-02: RECENT FINDINGS OF NOVEL BLOOD COMPONENTS’ AMYLOID-BETA MEASURES Alzheimer's & Dementia. 15: P526-P527. DOI: 10.1016/J.Jalz.2019.06.4441 |
0.321 |
|
| 2018 |
Lothian A, Lago L, Mukherjee S, Connor AR, Fowler C, McLean CA, Horne M, Masters CL, Cappai R, Roberts BR. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn. Metallomics : Integrated Biometal Science. PMID 30465671 DOI: 10.1039/C8Mt00223A |
0.586 |
|
| 2017 |
Rita Cardoso B, Hare DJ, Lind M, McLean CA, Volitakis I, Laws SM, Masters CL, Bush AI, Roberts BR. The APOE ε4 allele is associated with lower selenium levels in the brain: implications in Alzheimer's disease. Acs Chemical Neuroscience. PMID 28453930 DOI: 10.1021/Acschemneuro.7B00014 |
0.483 |
|
| 2017 |
Mukherjee S, Kapp EA, Lothian A, Roberts AM, Vasilev Y, Boughton B, Barnham KJ, Kok WM, Hutton CA, Masters CL, Bush A, Beckman JS, Dey SG, Roberts BR. Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry. Analytical Chemistry. PMID 28453255 DOI: 10.1021/Acs.Analchem.7B00941 |
0.622 |
|
| 2017 |
Roberts BR, Lind M, Wagen AZ, Rembach A, Frugier T, Li QX, Ryan TM, McLean CA, Doecke JD, Rowe CC, Villemagne VL, Masters CL. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. Brain : a Journal of Neurology. PMID 28383676 DOI: 10.1093/Brain/Awx057 |
0.497 |
|
| 2017 |
Cardoso BR, Hare DJ, Bush AI, Li QX, Fowler CJ, Masters CL, Martins RN, Ganio K, Lothian A, Mukherjee S, Kapp EA, Roberts BR. Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL). Journal of Alzheimer's Disease : Jad. PMID 28222503 DOI: 10.3233/Jad-160622 |
0.624 |
|
| 2017 |
Doecke JD, Whittle E, Villemagne VL, Masters CL, Roberts BR. [P2-263]: GRAPHICAL NETWORK ANALYSES INFORMS PET Aβ-AMYLOID BIOMARKER DISCOVERY VIA QUANTIFICATION OF INDIVIDUAL PEPTIDE CONNECTIONS Alzheimer's & Dementia. 13: P714-P714. DOI: 10.1016/J.Jalz.2017.06.916 |
0.407 |
|
| 2016 |
Roberts BR, Doecke JD, Rembach A, Yévenes LF, Fowler CJ, McLean CA, Lind M, Volitakis I, Masters CL, Bush AI, Hare DJ. Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid. Acta Neuropathologica Communications. 4: 119. PMID 27842602 DOI: 10.1186/S40478-016-0390-8 |
0.477 |
|
| 2016 |
Heffernan AL, Chidgey C, Peng P, Masters CL, Roberts BR. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts. Journal of Molecular Neuroscience : Mn. PMID 27498201 DOI: 10.1007/s12031-016-0804-x |
0.447 |
|
| 2016 |
Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and grey matter iron distribution in Alzheimer's disease frontal cortex. Neuroimage. PMID 27233149 DOI: 10.1016/J.Neuroimage.2016.05.057 |
0.394 |
|
| 2016 |
Hare DJ, Faux NG, Roberts BR, Volitakis I, Martins RN, Bush AI. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Metallomics : Integrated Biometal Science. PMID 26962965 DOI: 10.1039/C6Mt00019C |
0.356 |
|
| 2016 |
Hare DJ, Rembach A, Roberts BR. The Emerging Role of Metalloproteomics in Alzheimer's Disease Research. Methods in Molecular Biology (Clifton, N.J.). 1303: 379-89. PMID 26235079 DOI: 10.1007/978-1-4939-2627-5_22 |
0.33 |
|
| 2015 |
Ryan TM, Roberts BR, McColl G, Hare DJ, Doble PA, Li QX, Lind M, Roberts AM, Mertens HD, Kirby N, Pham CL, Hinds MG, Adlard PA, Barnham KJ, Curtain CC, et al. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 2871-84. PMID 25698727 DOI: 10.1523/Jneurosci.2912-14.2015 |
0.527 |
|
| 2015 |
Ryan TM, Kirby N, Mertens HD, Roberts B, Barnham KJ, Cappai R, Pham Cle L, Masters CL, Curtain CC. Small angle X-ray scattering analysis of Cu(2+)-induced oligomers of the Alzheimer's amyloid β peptide. Metallomics : Integrated Biometal Science. 7: 536-43. PMID 25687761 DOI: 10.1039/c4mt00323c |
0.48 |
|
| 2015 |
Hare DJ, Doecke JD, Faux NG, Rembach A, Volitakis I, Fowler CJ, Grimm R, Doble PA, Cherny RA, Masters CL, Bush AI, Roberts BR. Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation. Acs Chemical Neuroscience. 6: 398-402. PMID 25588002 DOI: 10.1021/Cn5003557 |
0.438 |
|
| 2015 |
Roberts BR, Hare DJ, McLean CA, Conquest A, Lind M, Li QX, Bush AI, Masters CL, Morganti-Kossmann MC, Frugier T. Traumatic brain injury induces elevation of Co in the human brain. Metallomics : Integrated Biometal Science. 7: 66-70. PMID 25424382 DOI: 10.1039/C4Mt00258J |
0.313 |
|
| 2015 |
Ryan TM, Roberts BR, McColl G, Hare DJ, Hinds MG, Barnham KJ, Curtain CC, Masters CL. F5-02-03: Targeting Aβ oligomer formation in Alzheimer's disease: Challenges and alternatives to oligomer-specific therapeutic avenues Alzheimer's & Dementia. 11: P305-P305. DOI: 10.1016/j.jalz.2015.07.429 |
0.463 |
|
| 2014 |
Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, Cherny RA, McLean C, Grimm R, Martins R, Ames D, Masters CL, Bush AI, Roberts BR. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics : Integrated Biometal Science. 6: 1216-9. PMID 24676028 DOI: 10.1039/C4Mt00060A |
0.462 |
|
| 2014 |
Pham CL, Kirby N, Wood K, Ryan T, Roberts B, Sokolova A, Barnham KJ, Masters CL, Knott RB, Cappai R, Curtain CC, Rekas A. Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study. Proteins. 82: 10-21. PMID 23733394 DOI: 10.1002/prot.24332 |
0.392 |
|
| 2014 |
Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 53-61. PMID 23491263 DOI: 10.1016/J.Jalz.2012.12.006 |
0.472 |
|
| 2014 |
Hare DJ, Lei P, Ayton S, Roberts BR, Grimm R, George JL, Bishop DP, Beavis AD, Donovan SJ, McColl G, Volitakis I, Masters CL, Adlard PA, Cherny RA, Bush AI, et al. An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta Chemical Science. 5: 2160-2169. DOI: 10.1039/C3Sc53461H |
0.33 |
|
| 2013 |
Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, Bush AI, Masters CL, Roberts BR. Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction. International Journal of Alzheimer's Disease. 2013: 623241. PMID 24228186 DOI: 10.1155/2013/623241 |
0.464 |
|
| 2013 |
Hare DJ, Grubman A, Ryan TM, Lothian A, Liddell JR, Grimm R, Matsuda T, Doble PA, Cherny RA, Bush AI, White AR, Masters CL, Roberts BR. Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics : Integrated Biometal Science. 5: 1656-62. PMID 24132241 DOI: 10.1039/C3Mt00227F |
0.348 |
|
| 2013 |
Rembach A, Ryan TM, Roberts BR, Doecke JD, Wilson WJ, Watt AD, Barnham KJ, Masters CL. Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. Biomarkers in Medicine. 7: 641-62. PMID 23905901 DOI: 10.2217/bmm.13.59 |
0.467 |
|
| 2013 |
Lothian A, Hare DJ, Grimm R, Ryan TM, Masters CL, Roberts BR. Metalloproteomics: principles, challenges and applications to neurodegeneration. Frontiers in Aging Neuroscience. 5: 35. PMID 23882215 DOI: 10.3389/fnagi.2013.00035 |
0.369 |
|
| 2013 |
Ryan TM, Caine J, Mertens HD, Kirby N, Nigro J, Breheney K, Waddington LJ, Streltsov VA, Curtain C, Masters CL, Roberts BR. Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. Peerj. 1: e73. PMID 23678397 DOI: 10.7717/peerj.73 |
0.433 |
|
| 2013 |
Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 171-82. PMID 23168449 DOI: 10.3233/Jad-121474 |
0.47 |
|
| 2013 |
Kok WM, Cottam JM, Ciccotosto GD, Miles LA, Karas JA, Scanlon DB, Roberts BR, Parker MW, Cappai R, Barnham KJ, Hutton CA. Synthetic dityrosine-linked β-amyloid dimers form stable, soluble, neurotoxic oligomers Chemical Science. 4: 4449-4454. DOI: 10.1039/C3Sc22295K |
0.406 |
|
| 2013 |
Ryan TM, Roberts BR, Streltsov VA, Nuttall SD, Masters CL. The Role of Aβ in Alzheimer's Disease Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties. 263-293. DOI: 10.1002/9783527654185.ch13 |
0.513 |
|
| 2012 |
McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, Ryan TM, Masters CL, Barnham KJ, Bush AI, Cherny RA. Utility of an improved model of amyloid-beta (Aβâ‚â‚‹â‚„â‚‚) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Molecular Neurodegeneration. 7: 57. PMID 23171715 DOI: 10.1186/1750-1326-7-57 |
0.476 |
|
| 2012 |
Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, White AR, Crouch PJ, Lim S, Leong SL, Wilkins S, George J, Roberts BR, Pham CL, Liu X, Chiu FC, et al. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. The Journal of Experimental Medicine. 209: 837-54. PMID 22473957 DOI: 10.1084/Jem.20112285 |
0.353 |
|
| 2012 |
Ryan TM, Friedhuber A, Lind M, Howlett GJ, Masters C, Roberts BR. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). The Journal of Biological Chemistry. 287: 16947-54. PMID 22461629 DOI: 10.1074/Jbc.M111.321778 |
0.487 |
|
| 2012 |
Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nature Medicine. 18: 291-5. PMID 22286308 DOI: 10.1038/Nm.2613 |
0.36 |
|
| 2012 |
Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA. The role of metallobiology and amyloid-β peptides in Alzheimer's disease. Journal of Neurochemistry. 120: 149-66. PMID 22121980 DOI: 10.1111/J.1471-4159.2011.07500.X |
0.525 |
|
| 2011 |
Acevedo KM, Hung YH, Dalziel AH, Li QX, Laughton K, Wikhe K, Rembach A, Roberts B, Masters CL, Bush AI, Camakaris J. Copper promotes the trafficking of the amyloid precursor protein. The Journal of Biological Chemistry. 286: 8252-62. PMID 21177866 DOI: 10.1074/Jbc.M110.128512 |
0.463 |
|
| 2011 |
Rembach A, Rowe C, Ellis K, Doecke J, Masters C, Martins R, Faux N, Duce J, Ames D, Volitakis I, Bush A, Roberts B, Trounson B, Fowler C, Pertile K, et al. Plasma copper and ceruloplasmin are not altered in Alzheimer's disease: Baseline data in the Australian Imaging Biomarker Lifestyle (AIBL) study of Ageing Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.386 |
0.433 |
|
| 2010 |
Lawson VA, Haigh CL, Roberts B, Kenche VB, Klemm HM, Masters CL, Collins SJ, Barnham KJ, Drew SC. Near-infrared fluorescence imaging of apoptotic neuronal cell death in a live animal model of prion disease. Acs Chemical Neuroscience. 1: 720-7. PMID 22778809 DOI: 10.1021/Cn100068X |
0.354 |
|
| 2009 |
McColl G, Roberts BR, Gunn AP, Perez KA, Tew DJ, Masters CL, Barnham KJ, Cherny RA, Bush AI. The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. The Journal of Biological Chemistry. 284: 22697-702. PMID 19574211 DOI: 10.1074/Jbc.C109.028514 |
0.361 |
|
| 2009 |
Hung L, Roberts B, Wilkins S, George J, Pham C, Lim S, Crouch P, Nurjono M, Gunawan L, Critch N, Sherratt N, Cherny R, Bush A, Masters C, Culvenor J, et al. P2.097 A reactive nitrogen species scavenger is neuroprotective in multiple Parkinson's disease animal models Parkinsonism & Related Disorders. 15: S115. DOI: 10.1016/S1353-8020(09)70448-1 |
0.396 |
|
| Show low-probability matches. |